Loading…

ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials

In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle...

Full description

Saved in:
Bibliographic Details
Published in:Computers in biology and medicine 2019-08, Vol.111, p.103339-103339, Article 103339
Main Authors: Grafféo, Nathalie, Latouche, Aurélien, Le Tourneau, Christophe, Chevret, Sylvie
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03
cites cdi_FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03
container_end_page 103339
container_issue
container_start_page 103339
container_title Computers in biology and medicine
container_volume 111
creator Grafféo, Nathalie
Latouche, Aurélien
Le Tourneau, Christophe
Chevret, Sylvie
description In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle these switches, the inverse probability of censoring weighting (IPCW) method has been proposed; however, it is still poorly used in RCT, notably because of its complex implementation. In particular, for time-to-event outcomes, it can be difficult to format data, especially when time-dependent covariates have to be managed, with different measurement times between patients. This paper aims to present the R package ipcwswitch with some guidance for the analysis of the treatment effect on survival in a hypothetical setting where all patients would have continued to take the randomization treatment. After a brief recall of the key principles of the IPCW method, each step of the implementation is described using a toy example. The guidelines are illustrated in a case study that aimed at evaluating the benefit of therapy based on tumour molecular profiling for advanced cancers, SHIVA01. •Handling treatment switches in the randomized clinical trial setting.•R package implementing the inverse probability of censoring weights (IPCW) method.•New R functions to facilitate data formatting.•Step-by-step tutorial to run the IPCW method.•Focus on a previously published randomized clinical trial, SHIVA01.
doi_str_mv 10.1016/j.compbiomed.2019.103339
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02349298v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0010482519302082</els_id><sourcerecordid>2280421650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03</originalsourceid><addsrcrecordid>eNqFkU1vEzEQhi0EomnhLyBLXOCQ4O_Y3NIKKFIkJARny-vYicPGXmwnUfn1eLstSFw4jT3zzDsevwBAjBYYYfFuv7DpMHQhHdxmQRBWLU0pVU_ADMulmiNO2VMwQwijOZOEX4DLUvYIIYYoeg4uKGaMLAWZgV9hsOdyDtXu3sNVhF_hYOwPs3XQpwxDPLlcHBxy6kwX-lDvYPLQulhSDnELzy5sd_X-FOoOmgjNMPTBmhpShDXBSdqVJgVtH2Ir9bDmYPryAjzzLbiXD_EKfP_44dvN7Xz95dPnm9V6btsWdU47oZjnSJmOScMJVhwRb4zyzCthKLPYSSeWXAqJPObUSm486TadaLcO0SvwdtLdmV4PORxMvtPJBH27Wusxhwhliih5wo19M7Ft459HV6o-hGJd35vo0rFoQiTFiAshGvr6H3Sfjjm2TUYKMYIFH4fLibI5lZKd__MCjPTopd7rv17q0Us9edlaXz0MOHZj7bHx0bwGXE-Aa793Ci7rYoOL1m1CdrbqTQr_n_IbCo-02Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2280421650</pqid></control><display><type>article</type><title>ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials</title><source>ScienceDirect Journals</source><creator>Grafféo, Nathalie ; Latouche, Aurélien ; Le Tourneau, Christophe ; Chevret, Sylvie</creator><creatorcontrib>Grafféo, Nathalie ; Latouche, Aurélien ; Le Tourneau, Christophe ; Chevret, Sylvie</creatorcontrib><description>In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle these switches, the inverse probability of censoring weighting (IPCW) method has been proposed; however, it is still poorly used in RCT, notably because of its complex implementation. In particular, for time-to-event outcomes, it can be difficult to format data, especially when time-dependent covariates have to be managed, with different measurement times between patients. This paper aims to present the R package ipcwswitch with some guidance for the analysis of the treatment effect on survival in a hypothetical setting where all patients would have continued to take the randomization treatment. After a brief recall of the key principles of the IPCW method, each step of the implementation is described using a toy example. The guidelines are illustrated in a case study that aimed at evaluating the benefit of therapy based on tumour molecular profiling for advanced cancers, SHIVA01. •Handling treatment switches in the randomized clinical trial setting.•R package implementing the inverse probability of censoring weights (IPCW) method.•New R functions to facilitate data formatting.•Step-by-step tutorial to run the IPCW method.•Focus on a previously published randomized clinical trial, SHIVA01.</description><identifier>ISSN: 0010-4825</identifier><identifier>EISSN: 1879-0534</identifier><identifier>DOI: 10.1016/j.compbiomed.2019.103339</identifier><identifier>PMID: 31442762</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Applications ; Bias ; Clinical trials ; Constitution ; Inverse probability weighting ; Methods ; Patients ; Randomization ; Randomized clinical trial ; Statistics ; Survival ; Survival analysis ; Switches ; Time dependence ; Treatment switch ; Tumors ; Weighting</subject><ispartof>Computers in biology and medicine, 2019-08, Vol.111, p.103339-103339, Article 103339</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><rights>2019. Elsevier Ltd</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03</citedby><cites>FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03</cites><orcidid>0000-0001-7227-7525 ; 0000-0001-9218-0333</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31442762$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://cnam.hal.science/hal-02349298$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Grafféo, Nathalie</creatorcontrib><creatorcontrib>Latouche, Aurélien</creatorcontrib><creatorcontrib>Le Tourneau, Christophe</creatorcontrib><creatorcontrib>Chevret, Sylvie</creatorcontrib><title>ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials</title><title>Computers in biology and medicine</title><addtitle>Comput Biol Med</addtitle><description>In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle these switches, the inverse probability of censoring weighting (IPCW) method has been proposed; however, it is still poorly used in RCT, notably because of its complex implementation. In particular, for time-to-event outcomes, it can be difficult to format data, especially when time-dependent covariates have to be managed, with different measurement times between patients. This paper aims to present the R package ipcwswitch with some guidance for the analysis of the treatment effect on survival in a hypothetical setting where all patients would have continued to take the randomization treatment. After a brief recall of the key principles of the IPCW method, each step of the implementation is described using a toy example. The guidelines are illustrated in a case study that aimed at evaluating the benefit of therapy based on tumour molecular profiling for advanced cancers, SHIVA01. •Handling treatment switches in the randomized clinical trial setting.•R package implementing the inverse probability of censoring weights (IPCW) method.•New R functions to facilitate data formatting.•Step-by-step tutorial to run the IPCW method.•Focus on a previously published randomized clinical trial, SHIVA01.</description><subject>Applications</subject><subject>Bias</subject><subject>Clinical trials</subject><subject>Constitution</subject><subject>Inverse probability weighting</subject><subject>Methods</subject><subject>Patients</subject><subject>Randomization</subject><subject>Randomized clinical trial</subject><subject>Statistics</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>Switches</subject><subject>Time dependence</subject><subject>Treatment switch</subject><subject>Tumors</subject><subject>Weighting</subject><issn>0010-4825</issn><issn>1879-0534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkU1vEzEQhi0EomnhLyBLXOCQ4O_Y3NIKKFIkJARny-vYicPGXmwnUfn1eLstSFw4jT3zzDsevwBAjBYYYfFuv7DpMHQhHdxmQRBWLU0pVU_ADMulmiNO2VMwQwijOZOEX4DLUvYIIYYoeg4uKGaMLAWZgV9hsOdyDtXu3sNVhF_hYOwPs3XQpwxDPLlcHBxy6kwX-lDvYPLQulhSDnELzy5sd_X-FOoOmgjNMPTBmhpShDXBSdqVJgVtH2Ir9bDmYPryAjzzLbiXD_EKfP_44dvN7Xz95dPnm9V6btsWdU47oZjnSJmOScMJVhwRb4zyzCthKLPYSSeWXAqJPObUSm486TadaLcO0SvwdtLdmV4PORxMvtPJBH27Wusxhwhliih5wo19M7Ft459HV6o-hGJd35vo0rFoQiTFiAshGvr6H3Sfjjm2TUYKMYIFH4fLibI5lZKd__MCjPTopd7rv17q0Us9edlaXz0MOHZj7bHx0bwGXE-Aa793Ci7rYoOL1m1CdrbqTQr_n_IbCo-02Q</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Grafféo, Nathalie</creator><creator>Latouche, Aurélien</creator><creator>Le Tourneau, Christophe</creator><creator>Chevret, Sylvie</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AL</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0N</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-7227-7525</orcidid><orcidid>https://orcid.org/0000-0001-9218-0333</orcidid></search><sort><creationdate>20190801</creationdate><title>ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials</title><author>Grafféo, Nathalie ; Latouche, Aurélien ; Le Tourneau, Christophe ; Chevret, Sylvie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Applications</topic><topic>Bias</topic><topic>Clinical trials</topic><topic>Constitution</topic><topic>Inverse probability weighting</topic><topic>Methods</topic><topic>Patients</topic><topic>Randomization</topic><topic>Randomized clinical trial</topic><topic>Statistics</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>Switches</topic><topic>Time dependence</topic><topic>Treatment switch</topic><topic>Tumors</topic><topic>Weighting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grafféo, Nathalie</creatorcontrib><creatorcontrib>Latouche, Aurélien</creatorcontrib><creatorcontrib>Le Tourneau, Christophe</creatorcontrib><creatorcontrib>Chevret, Sylvie</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Computing Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Computing Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Computers in biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grafféo, Nathalie</au><au>Latouche, Aurélien</au><au>Le Tourneau, Christophe</au><au>Chevret, Sylvie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials</atitle><jtitle>Computers in biology and medicine</jtitle><addtitle>Comput Biol Med</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>111</volume><spage>103339</spage><epage>103339</epage><pages>103339-103339</pages><artnum>103339</artnum><issn>0010-4825</issn><eissn>1879-0534</eissn><abstract>In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle these switches, the inverse probability of censoring weighting (IPCW) method has been proposed; however, it is still poorly used in RCT, notably because of its complex implementation. In particular, for time-to-event outcomes, it can be difficult to format data, especially when time-dependent covariates have to be managed, with different measurement times between patients. This paper aims to present the R package ipcwswitch with some guidance for the analysis of the treatment effect on survival in a hypothetical setting where all patients would have continued to take the randomization treatment. After a brief recall of the key principles of the IPCW method, each step of the implementation is described using a toy example. The guidelines are illustrated in a case study that aimed at evaluating the benefit of therapy based on tumour molecular profiling for advanced cancers, SHIVA01. •Handling treatment switches in the randomized clinical trial setting.•R package implementing the inverse probability of censoring weights (IPCW) method.•New R functions to facilitate data formatting.•Step-by-step tutorial to run the IPCW method.•Focus on a previously published randomized clinical trial, SHIVA01.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>31442762</pmid><doi>10.1016/j.compbiomed.2019.103339</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7227-7525</orcidid><orcidid>https://orcid.org/0000-0001-9218-0333</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0010-4825
ispartof Computers in biology and medicine, 2019-08, Vol.111, p.103339-103339, Article 103339
issn 0010-4825
1879-0534
language eng
recordid cdi_hal_primary_oai_HAL_hal_02349298v1
source ScienceDirect Journals
subjects Applications
Bias
Clinical trials
Constitution
Inverse probability weighting
Methods
Patients
Randomization
Randomized clinical trial
Statistics
Survival
Survival analysis
Switches
Time dependence
Treatment switch
Tumors
Weighting
title ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A13%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ipcwswitch:%20An%20R%20package%20for%20inverse%20probability%20of%20censoring%20weighting%20with%20an%20application%20to%20switches%20in%20clinical%20trials&rft.jtitle=Computers%20in%20biology%20and%20medicine&rft.au=Graff%C3%A9o,%20Nathalie&rft.date=2019-08-01&rft.volume=111&rft.spage=103339&rft.epage=103339&rft.pages=103339-103339&rft.artnum=103339&rft.issn=0010-4825&rft.eissn=1879-0534&rft_id=info:doi/10.1016/j.compbiomed.2019.103339&rft_dat=%3Cproquest_hal_p%3E2280421650%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2280421650&rft_id=info:pmid/31442762&rfr_iscdi=true